Healthcare -
Biotechnology - NASDAQ - US
$ 5.27
-0.189 %
$ 47 M
Market Cap
-20.27
P/E
ICCC - OPERATING INCOME
Operating Income ICCC - ImmuCell Corporation
-5.75 M
LAST VALUE
-61.49%
2 YEAR CAGR
-31.77%
5 YEAR CAGR
-76.54%
10 YEAR CAGR